Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4086174 | Revista Española de Cirugía Ortopédica y Traumatología | 2016 | 7 Pages |
Abstract
Intravenous administration of tranexamic acid, according to the described protocol, has presented a non-autotransfusion or allo-transfusion rate of 100%, with no increased incidence of thrombotic events. Thus, its use in this group of patients is recommended. The indication should be individualized, its use justified in the patient medical records, and informed consent is mandatory.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
J. Sanz-Reig, B. Parra Ruiz, J. Ferrández MartÃnez, J.F. MartÃnez López,